MAP4

Discontinued Product

0711 has been discontinued.

View all Glutamate (Metabotropic) Group II Receptors products.
说明: Potent group II mGlu agonist; also group III mGlu antagonist
化学名: (S)-2-Amino-2-methyl-4-phosphonobutanoic acid
纯度: ≥96% (HPLC)
说明书
引用文献 (1)
评论
文献 (4)

生物活性 for MAP4

MAP4 is a selective group III metabotropic glutamate receptor antagonist in some electrophysiological systems. Group II/group III agonist in certain neurochemical systems.

技术数据 for MAP4

分子量 197.13
公式 C5H12NO5P
储存 Store at RT
纯度 ≥96% (HPLC)
CAS Number 157381-42-5
PubChem ID 1795545
InChI Key HONKEGXLWUDTCF-YFKPBYRVSA-N
Smiles N[C@](CCP(O)(O)=O)(C)C(O)=O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书 for MAP4

分析证书/产品说明书
选择另一批次:

关键词: MAP4, MAP4 supplier, Potent, group, II, mGlur, agonists, specific, III, antagonists, Selective, potent, Group, Receptors, mGlu2, mGlu3, mGluR2, mGluR3, Glutamate, Metabotropic, mGlu4, mGluR4, mGlu6, mGluR6, mGlu7, mGluR7, mGlu8, mGlkuR8, (Metabotropic), 0711, Tocris Bioscience

1 篇 MAP4 的引用文献

引用文献是使用了 Tocris 产品的出版物。 MAP4 的部分引用包括:

Piet et al (2004) Physiological contribution of the astrocytic environment of neurons to intersynaptic crosstalk. J Neurosci 101 2151 PMID: 14766975


MAP4 的评论

目前没有该产品的评论。 Be the first to review MAP4 and earn rewards!

Have you used MAP4?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Metabotropic Glutamate Receptors Scientific Review

Metabotropic Glutamate Receptors Scientific Review

Written by Francine Acher, this review discusses the pharmacology and therapeutic potential of mGlu receptors, and the compounds acting upon them; compounds available from Tocris are listed.

Addiction Poster

Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.